Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

299 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evaluating the clinical utility of early exome sequencing in diverse pediatric outpatient populations in the North Carolina Clinical Genomic Evaluation of Next-generation Exome Sequencing (NCGENES) 2 study: a randomized controlled trial.
Staley BS, Milko LV, Waltz M, Griesemer I, Mollison L, Grant TL, Farnan L, Roche M, Navas A, Lightfoot A, Foreman AKM, O'Daniel JM, O'Neill SC, Lin FC, Roman TS, Brandt A, Powell BC, Rini C, Berg JS, Bensen JT. Staley BS, et al. Among authors: navas a. Trials. 2021 Jun 14;22(1):395. doi: 10.1186/s13063-021-05341-2. Trials. 2021. PMID: 34127041 Free PMC article. Clinical Trial.
Effectiveness of BNT162b2 Vaccine against Critical Covid-19 in Adolescents.
Olson SM, Newhams MM, Halasa NB, Price AM, Boom JA, Sahni LC, Pannaraj PS, Irby K, Walker TC, Schwartz SP, Maddux AB, Mack EH, Bradford TT, Schuster JE, Nofziger RA, Cameron MA, Chiotos K, Cullimore ML, Gertz SJ, Levy ER, Kong M, Cvijanovich NZ, Staat MA, Kamidani S, Chatani BM, Bhumbra SS, Bline KE, Gaspers MG, Hobbs CV, Heidemann SM, Maamari M, Flori HR, Hume JR, Zinter MS, Michelson KN, Zambrano LD, Campbell AP, Patel MM, Randolph AG; Overcoming Covid-19 Investigators. Olson SM, et al. N Engl J Med. 2022 Feb 24;386(8):713-723. doi: 10.1056/NEJMoa2117995. Epub 2022 Jan 12. N Engl J Med. 2022. PMID: 35021004 Free PMC article.
Effectiveness of Pfizer-BioNTech mRNA Vaccination Against COVID-19 Hospitalization Among Persons Aged 12-18 Years - United States, June-September 2021.
Olson SM, Newhams MM, Halasa NB, Price AM, Boom JA, Sahni LC, Irby K, Walker TC, Schwartz SP, Pannaraj PS, Maddux AB, Bradford TT, Nofziger RA, Boutselis BJ, Cullimore ML, Mack EH, Schuster JE, Gertz SJ, Cvijanovich NZ, Kong M, Cameron MA, Staat MA, Levy ER, Chatani BM, Chiotos K, Zambrano LD, Campbell AP, Patel MM, Randolph AG; Overcoming COVID-19 Investigators. Olson SM, et al. MMWR Morb Mortal Wkly Rep. 2021 Oct 22;70(42):1483-1488. doi: 10.15585/mmwr.mm7042e1. MMWR Morb Mortal Wkly Rep. 2021. PMID: 34673751 Free PMC article.
Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12-18 Years - United States, July-December 2021.
Zambrano LD, Newhams MM, Olson SM, Halasa NB, Price AM, Boom JA, Sahni LC, Kamidani S, Tarquinio KM, Maddux AB, Heidemann SM, Bhumbra SS, Bline KE, Nofziger RA, Hobbs CV, Bradford TT, Cvijanovich NZ, Irby K, Mack EH, Cullimore ML, Pannaraj PS, Kong M, Walker TC, Gertz SJ, Michelson KN, Cameron MA, Chiotos K, Maamari M, Schuster JE, Orzel AO, Patel MM, Campbell AP, Randolph AG; Overcoming COVID-19 Investigators. Zambrano LD, et al. MMWR Morb Mortal Wkly Rep. 2022 Jan 14;71(2):52-58. doi: 10.15585/mmwr.mm7102e1. MMWR Morb Mortal Wkly Rep. 2022. PMID: 35025852 Free PMC article.
Impact of COVID-19 pandemic on science communication.
Navas AL, Lunardelo PP, Lemos SMA, Ribeiro VV, Lopes LW. Navas AL, et al. Codas. 2024 Apr 26;36(2):e20240068. doi: 10.1590/2317-1782/20242024068pt. eCollection 2024. Codas. 2024. PMID: 38695433 Free article. English, Portuguese. No abstract available.
Neurotrophic keratopathy: General features and new therapies.
Vera-Duarte GR, Jimenez-Collado D, Kahuam-López N, Ramirez-Miranda A, Graue-Hernandez EO, Navas A, Rosenblatt MI. Vera-Duarte GR, et al. Among authors: navas a. Surv Ophthalmol. 2024 Apr 26:S0039-6257(24)00042-0. doi: 10.1016/j.survophthal.2024.04.004. Online ahead of print. Surv Ophthalmol. 2024. PMID: 38679146 Review.
299 results